News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
117,469 Results
Type
Article (6364)
Company Profile (4)
Press Release (111101)
Multimedia
Podcasts (3)
Webinars (3)
Section
Business (33433)
Career Advice (60)
Deals (6600)
Drug Delivery (15)
Drug Development (14023)
Employer Resources (8)
FDA (2593)
Job Trends (1718)
News (57467)
Policy (5558)
Tag
Academia (331)
Accelerated approval (8)
Adcomms (1)
Allergies (48)
Alliances (11446)
ALS (27)
Alzheimer's disease (274)
Antibody-drug conjugate (ADC) (102)
Approvals (2796)
Artificial intelligence (63)
Autoimmune disease (40)
Automation (3)
Bankruptcy (14)
Best Places to Work (1219)
Biosimilars (79)
Biotechnology (6)
Bladder cancer (44)
Brain cancer (10)
Breast cancer (86)
Cancer (899)
Cardiovascular disease (59)
Career advice (63)
Career pathing (2)
CAR-T (36)
CDC (5)
Cell therapy (106)
Cervical cancer (3)
Clinical research (12560)
Collaboration (436)
Company closure (1)
Compensation (54)
Complete response letters (15)
COVID-19 (762)
CRISPR (9)
C-suite (171)
Cystic fibrosis (22)
Data (1345)
Depression (36)
Dermatology (10)
Diabetes (65)
Diagnostics (1150)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (58)
Drug pricing (25)
Duchenne muscular dystrophy (84)
Earnings (13234)
Editorial (4)
Employer branding (1)
Employer resources (8)
Events (12475)
Executive appointments (122)
FDA (3330)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (245)
Gene editing (26)
Generative AI (4)
Gene therapy (104)
GLP-1 (157)
Government (590)
Grass and pollen (4)
Guidances (106)
Healthcare (2250)
HIV (8)
Huntington's disease (4)
IgA nephropathy (28)
Immunology and inflammation (28)
Immuno-oncology (16)
Indications (32)
Infectious disease (813)
Inflammatory bowel disease (45)
Inflation Reduction Act (2)
Influenza (32)
Intellectual property (56)
Interviews (5)
IPO (2471)
IRA (3)
Job creations (558)
Job search strategy (57)
JPM (5)
Kidney cancer (3)
Labor market (5)
Layoffs (47)
Leadership (2)
Legal (1204)
Liver cancer (22)
Longevity (2)
Lung cancer (151)
Lymphoma (81)
Machine learning (2)
Management (3)
Manufacturing (171)
MASH (44)
Medical device (1899)
Medtech (1912)
Mergers & acquisitions (4379)
Metabolic disorders (203)
mRNA (14)
Multiple sclerosis (40)
NASH (4)
Neurodegenerative disease (58)
Neuropsychiatric disorders (18)
Neuroscience (524)
NextGen: Class of 2026 (443)
Non-profit (241)
Now hiring (1)
Obesity (77)
Opinion (17)
Ovarian cancer (44)
Pain (25)
Pancreatic cancer (33)
Parkinson's disease (57)
Partnered (4)
Patents (86)
Patient recruitment (97)
Peanut (16)
People (8730)
Pharmaceutical (2)
Pharmacy benefit managers (4)
Phase 1 (3517)
Phase 2 (5436)
Phase 3 (4775)
Pipeline (1490)
Policy (18)
Postmarket research (404)
Preclinical (1171)
Press Release (3)
Prostate cancer (44)
Psychedelics (3)
Radiopharmaceuticals (54)
Rare diseases (178)
Real estate (1099)
Recruiting (3)
Regulatory (4771)
Reports (11)
Research institute (375)
Resumes & cover letters (2)
Rett syndrome (14)
RNA editing (2)
RSV (10)
Schizophrenia (35)
Series A (47)
Series B (34)
Service/supplier (1)
Sickle cell disease (12)
Special edition (2)
Spinal muscular atrophy (11)
Sponsored (3)
Startups (638)
Stomach cancer (2)
Supply chain (15)
Tariffs (7)
The Weekly (3)
Vaccines (179)
Venture capital (11)
Weight loss (36)
Women's health (13)
Date
Last 7 days (108)
Last 30 days (402)
Last 365 days (4960)
2026 (1298)
2025 (5019)
2024 (5950)
2023 (6899)
2022 (12057)
2021 (10256)
2020 (8694)
2019 (6855)
2018 (5187)
2017 (5862)
2016 (5311)
2015 (6433)
2014 (4758)
2013 (4077)
2012 (4260)
2011 (4302)
2010 (3960)
Location
Africa (164)
Alabama (8)
Arizona (13)
Asia (23730)
Australia (2909)
California (1227)
Canada (572)
China (458)
Colorado (20)
Connecticut (45)
Delaware (66)
Europe (34773)
Florida (200)
Georgia (53)
Illinois (76)
India (51)
Indiana (47)
Japan (304)
Kansas (7)
Kentucky (2)
Louisiana (2)
Maine (8)
Maryland (193)
Massachusetts (1196)
Michigan (17)
Minnesota (56)
Missouri (5)
Montana (1)
Nebraska (4)
Nevada (22)
New Hampshire (5)
New Jersey (630)
New Mexico (5)
New York (528)
North Carolina (276)
Northern California (575)
Ohio (22)
Oregon (2)
Pennsylvania (329)
Puerto Rico (1)
Rhode Island (4)
South America (181)
South Carolina (14)
Southern California (543)
Tennessee (7)
Texas (127)
United States (5319)
Utah (38)
Virginia (72)
Washington D.C. (5)
Washington State (122)
Wisconsin (12)
117,469 Results for "pro2kem ltd uk".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
• Meetings with all four regulatory agencies scheduled to occur in the second quarter of 2026, with expected Phase 3 commencement in the third quarter of 2026 initially in Australia • Commencing the Phase 3 confirmatory study is a pre-requisite to being granted a Biologics License Application (BLA) under the Accelerated Approval Program in the U.S. and Conditional Marketing Authorisations (CMAs) in the U.K. & Europe
March 27, 2026
·
5 min read
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
Talks between pharma and successive U.K. governments have failed to deliver the market access terms that the industry wants, contributing to a pullback in investment.
October 1, 2025
·
4 min read
·
Nick Paul Taylor
Opinion
The Urgent Need To Redefine the Future of UK Biotech
As major pharmas pull away from the U.K. and the U.S. risks ceding its lead through a national brain drain, the U.K. must create a new, more robust model for innovation.
October 1, 2025
·
6 min read
·
Kerstin Papenfuss
Insights
New UK/EU Rules and AI Adoption Define CRO Priorities for 2026
With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, CROs are zeroing in on study timelines, AI/ML and data privacy as the industry’s next pressure points.
December 3, 2025
·
4 min read
·
Jennifer C. Smith-Parker
Press Releases
Medicus Pharma Ltd Announces a Definitive Agreement to Acquire Antev Ltd. UK
Antev Shareholders to Receive Aggregate ~17% Equity Stake in Medicus plus US$65 Million in Contingent Payments
June 30, 2025
·
10 min read
Press Releases
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
March 4, 2026
·
6 min read
Press Releases
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
March 11, 2026
·
6 min read
Drug pricing
Sanofi Joins Growing Group of Pharmas Pulling Back From UK
Merck, Eli Lilly and AstraZeneca have similarly suspended or outright canceled investments in the U.K. in the past week after a sizeable increase in a mandatory levy in the region.
September 16, 2025
·
2 min read
·
Tristan Manalac
Europe
AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility
AstraZeneca in January also stopped its $610 million plans to construct a vaccine R&D and manufacturing site in the U.K.
September 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Velocity Clinical Research Appoints UK Medical Director
February 12, 2026
·
4 min read
1 of 11,747
Next